仁和药业：仁和集团拟减持不超过300万股

Core Viewpoint - Renhe Pharmaceutical (000650.SZ) announced a plan for its parent company, Renhe (Group) Development Co., Ltd., to reduce its shareholding by up to 3,000,000 shares, representing a maximum of 0.2143% of the total share capital within three months from the announcement date [1] Summary by Sections - Share Reduction Plan - The reduction will be executed through centralized bidding or block trading methods [1] - The adjustment of the reduction quantity will occur if there are corporate actions such as stock dividends, capital increases, or new share issuances during the reduction period, but the percentage of total share capital will remain unchanged [1]